✦ LIBER ✦

Comparison of Methods for Grading Gastrointestinal and Pancreatic Well-Differentiated Neuroendocrine Tumors

✍ Scribed by Goodell, Pamela P. ;Krasinskas, Alyssa M. ;Hartman, Douglas J.

Book ID: 122241451
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 64 KB
Volume: 140
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(11)63636-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Methods for Proliferative

Comparison of Methods for Proliferative Index Analysis for Grading Pancreatic Well-Differentiated Neuroendocrine Tumors

✍ Goodell, P. P.; Krasinskas, A. M.; Davison, J. M.; Hartman, D. J. 📂 Article 📅 2012 🏛 American Society for Clinical Pathology 🌐 English ⚖ 384 KB

Hypomethylation of LINE-1 and Alu in wel

Hypomethylation of LINE-1 and Alu in well-differentiated neuroendocrine tumors (pancreatic endocrine tumors and carcinoid tumors)

✍ Choi, In-Seon; Estecio, Marcos R H; Nagano, Yasuhiko; Kim, Do Ha; White, Jill A; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 193 KB

Analysis of risk factors for recurrence

Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification

✍ Tsutsumi, Kosuke; Ohtsuka, Takao; Fujino, Minoru; Nakashima, Hiroshi; Aishima, S 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 277 KB

Allelic alterations in well-differentiat

Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors

✍ Do Ha Kim; Yasuhiko Nagano; In-Seon Choi; Jill A. White; James C. Yao; Asif Rash 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

## Abstract Well‐differentiated neuroendocrine tumors (WDNT, carcinoid tumors) are uncommon indolent neoplasms. The genetic alterations of these tumors are not well characterized. We used genome‐wide high‐density single nucleotide polymorphism (SNP) array analysis to detect copy number alterations

FDA Approval Summary: Sunitinib for the

FDA Approval Summary: Sunitinib for the Treatment of Progressive Well-Differentiated Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors

✍ Blumenthal, G. M.; Cortazar, P.; Zhang, J. J.; Tang, S.; Sridhara, R.; Murgo, A. 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 137 KB

Genomic Alterations in Well-Differentiat

Genomic Alterations in Well-Differentiated Gastrointestinal and Bronchial Neuroendocrine Tumors (Carcinoids): Marked Differences Indicating Diversity in Molecular Pathogenesis

✍ Jianming Zhao; Roland R. de Krijger; Dorette Meier; Ernst-Jan M. Speel; Parvin S 📂 Article 📅 2000 🏛 American Society for Investigative Pathology 🌐 English ⚖ 306 KB